[68Ga]-FF58
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for [68Ga]-FF58, covering 2025-10-10 to 2025-10-10. Get the full timeline:
Most recent: Clinical Trial Update: Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins. [EARLY_Phase 1]